- €30.91bn
- €33.26bn
- €5.25bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,913 | 5,347 | 5,777 | 5,517 | 5,252 |
Cost of Revenue | |||||
Gross Profit | 3,645 | 3,984 | 4,339 | 3,843 | 3,545 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,845 | 4,376 | 4,493 | 4,934 | 4,648 |
Operating Profit | 1,068 | 971 | 1,284 | 583 | 604 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 960 | 880 | 1,226 | 511 | 441 |
Provision for Income Taxes | |||||
Net Income After Taxes | 814 | 761 | 1,056 | 420 | 343 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 791 | 732 | 1,059 | 418 | 343 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 792 | 732 | 1,058 | 418 | 343 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.41 | 4.44 | 5.59 | 2.56 | 1.4 |
Dividends per Share |